2012 News Releases – Quarter 3
BIOHEART RENEGOTIATES COMPANY NOTE WITH FAVORABLE TERMS
Bioheart, Inc. (BHRT.OB) has renegotiated the terms of a Company note in the amount of $572,000 held by NorthStar Biotech, LLC, a consortium of Bioheart Directors and Shareholders, led by Bioheart Director Chuck Hart.
BIOHEART RECEIVES $ 2 MILLION TERM SHEET
INVESTMENT OFFER FROM GRUPO VITALMEX, A GLOBAL
LEADER IN HEALTHCARE IN LATIN AMERICA AND EUROPE
Bioheart, Inc. (BHRT.OB) announced today it has received a non-binding term sheet and investment offer in the amount of $ 2 million from Grupo Vitalmex in Mexico, a global leader in the healthcare sector in Latin America and
Europe (www.vitalmex.com.mx).